SSW
GILD icon

Smith Shellnut Wilson’s Gilead Sciences GILD Stock Holding History

Smith Shellnut Wilson’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,475
Closed -$249K – 127
2017
Q4 		$249K Hold
3,475
– – 0.21% 107
2017
Q3 		$282K Sell
3,475
-726
-17% -$55.5K 0.25% 88
2017
Q2 		$350K Sell
4,201
-100
-2% -$6.65K 0.36% 58
2017
Q1 		$292K Hold
4,301
– – 0.27% 92
2016
Q4 		$308K Buy
+4,301
New +$320K 0.3% 76

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Smith Shellnut Wilson's GILD Position: Q1 2018 in Review

Smith Shellnut Wilson sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 3,475 shares — an estimated $249K sold.

Smith Shellnut Wilson first reported a position in GILD in Q4 2016 and held it in 5 quarters. The position peaked at $350K in Q2 2017. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Smith Shellnut Wilson reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Smith Shellnut Wilson sold 3,475 Gilead Sciences shares in Q1 2018, an estimated $249K.
  • Smith Shellnut Wilson first reported a position in Gilead Sciences in Q4 2016 and held it in 5 quarters.
  • Smith Shellnut Wilson's Gilead Sciences position peaked at $350K in Q2 2017.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Smith Shellnut Wilson's 13F filing for Q1 2018, filed 24 Apr 2018.